{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-034668","form_type":"8-K","ticker":"NXPL","cik":"0001058307","company_name":"NextPlat Corp","filed_at":"2025-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.684604+00:00","generated_at":"2026-05-16T20:07:07.655918+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NextPlat Q3 revenue $13.8M, net loss narrows 48% YoY; sees Q4 improvement","bullets":["Revenue $13.8M down from $15.4M YoY; gross margin 19.9% vs 23.2%.","Net loss to common $2.2M ($0.08/sh) vs $4.2M ($0.22); cash $13.9M.","OpEx cut to $4.7M from $7.8M; annual overhead reduced >$2M via headcount cuts.","Healthcare added 3,000+ high-margin prescriptions/month; expanded government subcontract.","e-Commerce: GTC exclusive Nordic distributor; OPKO China sell-through high; FL Sunshine in UK/EU."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-034668","json":"https://secwatch.observer/filing/0001437749-25-034668.json","markdown":"https://secwatch.observer/filing/0001437749-25-034668.md","text":"https://secwatch.observer/filing/0001437749-25-034668.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1058307/000143774925034668/0001437749-25-034668-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1058307/000143774925034668/nxpl20250819_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T20:07:07.655918+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}